Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naive and bona fide regulatory T cells.
Purity:
>99.0%
CAS Number:
[288392-69-8]
* VAT and and shipping costs not included. Errors and price changes excepted